[SCHEDULE 13G] Lunai Bioworks Inc. SEC Filing

Rhea-AI Filing Summary

Lunai Bioworks Inc. received a joint Schedule 13G from Laksya Ventures Inc. and Neil Persh reporting beneficial ownership of 22,163,978 shares of common stock, representing 9.6% of 230,928,963 shares outstanding (per the issuer's Schedule 14A as of July 15, 2025). The 22,163,978 shares comprise 18,997,168 shares issued to Laksya Ventures upon conversion of convertible notes, 500,000 shares held directly by Laksya Ventures, and 2,666,810 shares held directly by Mr. Persh. Laksya Ventures is owned and controlled by Mr. Persh, who exercises sole voting and dispositive power over the reported shares. The filing includes a certification that the securities were not acquired to change or influence control of the issuer.

Insights

Financial Analyst

TL;DR: A single insider and his controlled entity report a notable 9.6% stake, created largely by convertible note conversions.

The Schedule 13G shows a meaningful minority position equal to 22.16 million shares or 9.6% of outstanding stock, largely resulting from conversions of convertible notes into equity. The disclosure clarifies ownership split and voting/dispositive authority, which concentrates control and economic exposure in Mr. Persh. For investors, this is material information about ownership structure but does not by itself indicate a change in corporate control, given the certification included in the filing.

Corporate Governance Expert

TL;DR: Ownership and control are concentrated: the CEO controls both the reporting entity and the shares reported.

The filing documents that Laksya Ventures, owned and controlled by Neil Persh, and Mr. Persh jointly report beneficial ownership of 9.6% of shares. The filing specifies that Mr. Persh exercises sole voting and dispositive power over the reported shares. The Schedule 13G classification and the included certification indicate the holders believe the stake is passive rather than intended to effect control, but the governance implication is clear: a significant block is under the influence of one individual.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Lunai Bioworks Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

236078101

(CUSIP Number)

07/07/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 236078101

1

Names of Reporting Persons

Laksya Ventures Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 22,163,978.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 22,163,978.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

22,163,978.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.6 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: 1. Represents 18,997,168 Shares held by Laksya Ventures, Inc. ("Laksya Ventures") that were issued upon conversion of convertible notes as reflected on the Form 8-K of Lunai Bioworks, Inc., a Delaware corporation ("Issuer"), filed with the SEC on July 9, 2025, 500,000 shares of common stock held directly by Laksya Ventures, and 2,666,810 shares of common stock held by Mr. Persh. Laksya Ventures is beneficially owned and controlled by Mr. Persh, who exercises sole voting and investment power. 2. Based on 230,928,963 shares of common stock, $0.0001 par value per share, issued and outstanding as of July 15, 2025, as per the Issuer's Schedule 14A filed with the SEC on July 30, 2025.

SCHEDULE 13G

CUSIP No. 236078101

1

Names of Reporting Persons

Neil Persh

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 22,163,978.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 22,163,978.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

22,163,978.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.6 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: 1. Represents 18,997,168 Shares held by Laksya Ventures Inc., ("Laksya Ventures") that were issued upon conversion of convertible notes as reflected on the Form 8-K of Lunai Bioworks, Inc., a Delaware corporation ("Issuer"), filed with the SEC on July 9, 2025, 500,000 shares of common stock held directly by Laksya Ventures, and 2,666,810 shares of common stock held by Mr. Persh. Laksya Ventures is beneficially owned and controlled by Mr. Persh, who exercises sole voting and investment power. 2. Based on 230,928,963 shares of common stock, $0.0001 par value per share, issued and outstanding as of July 15, 2025, as per the Issuer's Schedule 14A filed with the SEC on July 30, 2025.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Lunai Bioworks Inc.
(b)	Address of issuer's principal executive offices: CENTURY CITY MEDICAL PLAZA, 2080 CENTURY CITY EAST, SUITE 906 LOS ANGELES, CALIFORNIA, 90067.
Item 2.
(a)	Name of person filing: This Schedule 13G is being jointly filed by Laksya Ventures Inc., a New York corporation ("Laksya Ventures"), and Neil Persh ("Mr. Persh" and, together with Laksya Ventures, collectively, the "Reporting Persons"). Laksya Ventures is a corporation owned and controlled by Mr. Persh, and in such capacity, exercises the sole voting and investment power over the Shares of the Company held for the account of Laksya Ventures.
(b)	Address or principal business office or, if none, residence: 888 7th Avenue, 40th Floor, New York, NY 10019
(c)	Citizenship: Laksya Ventures is a New York corporation. Mr. Persh is a citizen of the United States of America.
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 236078101
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: All percentages of Shares outstanding contained herein are based on 230,928,963 Shares of the Company issued and outstanding as of July 15, 2025, as disclosed on the Company's Schedule 14A filed with the SEC on July 30, 2025. As of the date hereof, Laksya Ventures may be deemed to have beneficial ownership of 22,163,978 Shares. As of the date hereof, Mr. Persh may be deemed to have beneficial ownership of 22,163,978 Shares, representing 2,666,810 Shares held directly by Mr. Persh and 19,497,168 Shares held by Laksya Ventures.
(b)	Percent of class: The Shares beneficially owned by the Reporting Persons represent 9.6% of the total outstanding Shares.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Mr. Persh may be deemed to have the sole power to vote or direct the vote of all of the 22,163,978 Shares.
	(ii) Shared power to vote or to direct the vote: Laksya Ventures may be deemed to share the power to vote or direct the vote of all of the 22,163,978 Shares with Mr. Persh.
	(iii) Sole power to dispose or to direct the disposition of: Mr. Persh may be deemed to have the sole power to dispose or direct the disposition of all of the 22,163,978 Shares.
	(iv) Shared power to dispose or to direct the disposition of: Laksya Ventures may be deemed to share the power to dispose or direct the disposition of all of the 22,163,978 Shares.
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Laksya Ventures Inc.

Signature:	/s/ Neil Persh
Name/Title:	Chief Executive Officer
Date:	09/26/2025

Neil Persh

Signature:	/s/ Neil Persh
Name/Title:	Self
Date:	09/26/2025